Helix is the leading population genomics company working at the intersection of clinical care, research, and genomics. Its end-to-end platform enables health systems, life sciences companies, and payers to advance genomic research and accelerate the integration of genomic data into clinical care. Powered by one of the world’s largest CLIA / CAP next-generation sequencing labs and its proprietary Exome+® assay, Helix supports all aspects of population genomics including recruitment and engagement, clinically actionable disease screening, return of results, and basic and translational research.

Analytics

Biotechnology

Health & Wellness

Information Technology

Helix

James Lu

Hylton Kalvaria

Sheren Chiang

Stefano Menti

Leslie Liang

Sarah Bobulsky

Sharoni Jacobs

Jim Chou 

Craig Newman

Will Lee

Kirsten Mouritsen

Rebecca Schapiro 

Gloria Lee

The Biotechnology and Life Sciences team at Helix focuses on advancing genomic research and integrating genomic data into clinical applications. This multidisciplinary team collaborates with health systems and life sciences companies to develop innovative solutions for disease screening, targeted treatments, and education. By leveraging expertise in bioinformatics, data engineering, medical affairs, and user experience, they drive initiatives that enhance the understanding of population genomics and improve patient outcomes.

Biotechnology and Life Sciences

Research and Development

Software Engineering

Leadership Team

Biotechnology and Life Sciences

About

Team members

Other teams at Helix

Research and Development

Software Engineering

Leadership Team